SCI's 8th ANNUAL
PRICING, TRADING & RISK SEMINAR

7 October 2015, New York

Venue: 3rd Floor, Bank of America, 250 Vesey Street (formerly Four World Financial Center), New York, NY 10007

INTRODUCTION
SCI's 8th Annual US conference is an invaluable chance to get updates on the latest regulatory news and the implications for your business. You can also get great insights into valuations and IPV and immediately put ideas to work. This year we'll also look at the private label RMBS market and discuss the opportunity for re-growth of that always in-demand asset class. Plus much more - see below for a full agenda, and an idea of delegates that will attend.

DELEGATES WHO ATTENDED PREVIOUSLY REMARKED:
I thought the first two sessions of the day were valuable. The second one's moderator was prepared and the structure of the panel was very organized and yielded much benefit to the audience.
-    Regulator

I liked the set-up with a good number of small breaks to network.
-    IPV, Investment Bank

I thought the format of the day worked with short breaks between sessions. And I thought the range of topics worked too.
-    Family Office

I thought it was a well-focused event
-    Securities Broker

THIS EVENT IS KINDLY SPONSORED BY

REGISTRATION DETAILS

Delegate registration is $250

CLICK HERE TO REGISTER

Click here to view last year's delegate list.

AGENDA

9:00 KEYNOTE SPEECH

Chris DiAngelo - Katten, Muchin Rosenman:

"The impact of the Dodd Frank Act on the US Securitization Market"
As well as speaking on the effects of the Dodd-Frank Act on the US Securitisation Market, Chris will also talk about the current state of mortgage Finance, the emerging Marketplace Lending Asset Class, Liquidity and Risk Retention.

Get Chris' slide deck

9:20 REGULATORY UPDATE: CONSEQUENCES FOR INVESTMENT, TRADING & ISSUANCE

How is the US structured finance market coping with the implementation of new regulations from an investment, trading and issuance standpoint?
- How is regulation shaping the new-issue market?
- How are regulations affecting investor appetite and trading strategies?
- What are the main issues still to be ironed out? Are institutions ready to comply?
- Risk Retention, the REG AB II Rule (offering, disclosure and reporting requirements), market reaction to Volker rule implementation, US consequences of Basel III

Moderator:
Deborah Festa, Milbank
Panel:
Robert Hynes, FHFA
Mario Verna, Guggenheim
Dan Sullivan, PWC
Rich Michalek, RJM

BREAK

10:40 TRADER ROUNDTABLE

- Pricing issues; liquidity issues; pricing sources; transparency of data.
- Intended/unintended regulatory consequences
- Trace/FINRA bond reporting. Reporting times shortened from 45 minutes to 15 minutes as of   December. What impact on liquidity?
- Block trades and FINRA - solutions?

Moderator:
Jennifer Press, Duff & Phelps
Panel:
Antonio Blasetti, Brean Capital
Miguel Vazquez, GK Baum
Chris Moses, Janney Montgomery Scott
Vivek Baliga, KGS Alpha

BREAK

11:45: INVESTOR PANEL

How risk retention rules are impacting investment strategies.
Where does value currently lie?
Risk appetite? Movement across the capital structure?
New generation products vs more traditional SF (e.g. Fannie Mae CAS/Freddie Mac STACR, Single-family rental deals, Market-place lending.)

Moderator:
John Uhlein, Grenadier Capital
Panel:
Brad Golding, CRC
Stuart Lippman, Tiedemann
Jeff Herlyn, Tetragon
Sameer Tikoo, Partner Re

12.40 LUNCH

1.30 TWO STREAMS:

2:20: REGULATIONS: PRICING & VALUATIONS

Unintended/unexpected consequences of new regulation on pricing
How are regulations creating relative value opportunities for investors? (E.g. Volker Rule leading to bank sell-off of certain CLOs)
Liquid versus illiquid securities - where do the pricing challenges lie
Data sources - do we need more? Do we have too many?

Moderator:
Melissa Brady, McGladrey
Panel:
Ajit Gupta, PriceServe
Matt Lewis, New Oak
Rick Fingeret, Ernst & Young
Cindy Ma, Houlihan Lokey
Matt Rose, Thomson Reuters

BREAK

3:40: THE PRIVATE-LABEL RMBS MARKET

Risk retention and consequences for the private label market
Impact of foreclosure timelines on RMBS valuations
Post QM/ATR rule implementation - is it just not viable or cost effective to issue?
Pricing implications for QM vs non-QM products...Relative value?
Issuance prospects? Where does the market go from here?

Moderator:
John Uhlein, Grenadier Capital
Panel:
Corina Gonzalez, DBRS
Vincent Varca, FTI Consulting
Jack Kahan, Kroll Bond Ratings
Kevin Dwyer, Morningstar

------4.30 CLOSE-------

** NEW FEATURES FOR 2016**
Throughout the event delegates can also benefit from:

"ASK THE EXPERTS"
Working groups hosted by domain experts to discuss delegates' questions in an informal setting in groups of 10 throughout the breaks.

WORKSHOPS
Pricing & Valuation techniques of illiquid assets such as CLOs

back to top